Faeth Therapeutics, Inc. (FTH)
19.51
+0.71
(+3.78%)
USD |
NASDAQ |
Oct 19, 15:05
Faeth Therapeutics Price : 19.51 for Oct. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 21.00 | 21.00 | 18.29 | 18.80 | 595942.0 |
| Oct 15, 2026 | 19.90 | 21.39 | 19.90 | 20.60 | 231651.0 |
| Oct 14, 2026 | 20.93 | 21.26 | 19.85 | 20.00 | 421407.0 |
| Oct 13, 2026 | 23.29 | 23.53 | 21.34 | 21.51 | 350378.0 |
| Oct 12, 2026 | 26.00 | 26.00 | 23.00 | 23.25 | 309830.0 |
| Oct 09, 2026 | 25.21 | 26.64 | 25.21 | 26.03 | 197160.0 |
| Oct 08, 2026 | 25.12 | 26.16 | 23.67 | 25.61 | 346317.0 |
| Oct 07, 2026 | 26.71 | 27.02 | 23.95 | 24.92 | 322640.0 |
| Oct 06, 2026 | 26.96 | 29.64 | 26.00 | 26.89 | 289151.0 |
| Oct 05, 2026 | 28.31 | 28.33 | 25.78 | 27.10 | 412835.0 |
| Oct 02, 2026 | 28.32 | 29.50 | 27.37 | 28.35 | 187923.0 |
| Oct 01, 2026 | 29.56 | 31.13 | 27.66 | 28.27 | 268483.0 |
| Sep 30, 2026 | 28.49 | 30.18 | 27.66 | 29.74 | 356524.0 |
| Sep 29, 2026 | 27.77 | 28.21 | 26.99 | 28.07 | 250818.0 |
| Sep 28, 2026 | 27.84 | 28.17 | 26.58 | 27.77 | 195647.0 |
| Sep 25, 2026 | 28.93 | 28.93 | 27.60 | 28.00 | 328189.0 |
| Sep 24, 2026 | 31.05 | 31.06 | 27.66 | 29.05 | 608164.0 |
| Sep 23, 2026 | 32.71 | 33.95 | 31.34 | 31.55 | 435049.0 |
| Sep 22, 2026 | 33.31 | 33.68 | 32.18 | 33.40 | 633533.0 |
| Sep 21, 2026 | 34.50 | 34.81 | 32.11 | 33.29 | 379204.0 |
| Sep 18, 2026 | 35.29 | 35.57 | 34.33 | 34.50 | 2.198M |
| Sep 17, 2026 | 34.90 | 36.61 | 34.08 | 35.13 | 362997.0 |
| Sep 16, 2026 | 36.56 | 37.44 | 33.76 | 34.24 | 572403.0 |
| Sep 15, 2026 | 38.75 | 39.89 | 34.88 | 35.37 | 209395.0 |
| Sep 14, 2026 | 37.65 | 40.12 | 36.52 | 39.09 | 265888.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Opus Genetics, Inc. | 3.81 |
| Nuvectis Pharma, Inc. | 18.68 |
| ACADIA Pharmaceuticals, Inc. | 19.68 |
| Alnylam Pharmaceuticals, Inc. | 235.82 |
| Anika Therapeutics, Inc. | 20.28 |
Price Related Metrics
| PEG Ratio | -0.0001 |
| Price to Book Value | 2.914 |
| Earnings Yield | -726.0% |
| Market Cap | 504.00M |
| PEGY Ratio | -0.0001 |